Home » High-Quality Health Information » Health Topics » Macular Degeneration » Study: NCT01033721

| Print this page

• Home
• High-Quality
  Health Information
  • Health Topics
  • Health Resources
• Understanding Health Research
  • What is health research?
  • Is health research safe?
  • Is health research
    right for me?
• Health Research in Massachusetts
  • Search Ongoing Studies
  • Community-Engaged Research Projects
  • Community Health Centers

Title:	Phase I Study of Palomid 529 a Dual TORC1/2 Inhibitor of the PI3K/Akt/mTOR Pathway for Advanced Neovascular Age-Related Macular Degeneration
Status:	Recruiting participants
Conditions:	Age-Related Macular Degeneration
Interventions:	Drug: Palomid 529
Health Topics:	Macular Degeneration, Retinopathy
View this study on ClinicalTrials.gov

Contact Information

---

© Community Connect to Research, 2012